Le Lézard
Classified in: Health, Business
Subjects: CCA, TDS, FVT

Life Time to Participate in BofA Securities 2024 Consumer & Retail Conference


CHANHASSEN, Minn., March 4, 2024 /PRNewswire/ -- Life Time Group Holdings, Inc. ("Life Time" or the "Company") (NYSE: LTH) today announced the Company will participate in the BofA Securities 2024 Consumer & Retail Conference, which will be held March 12-13, 2024, at 1 Hotel South Beach in Miami Beach, Florida.

Life Time Fireside Chat ? March 12, 2024, at 1:00pm ET
Life Time Founder, Chairman and Chief Executive Officer, Bahram Akradi, and interim Chief Financial Officer, Erik Weaver, will participate in a fireside chat discussion moderated by BofA Securities Analyst, Alex Perry.

A webcast of the fireside chat is available at: LTH Fireside Chat - BofA Securities Conference.

The fireside chat also may be accessed, along with any related presentation material, on the Company's Investor Relations website where it will be available through June 11, 2024.

About Life Time
Life Time (NYSE: LTH) empowers people to live healthy, happy lives through its portfolio of more than 170 athletic country clubs across the United States and Canada. The Company's healthy way of life communities and ecosystem address all aspects of healthy living, healthy aging and healthy entertainment for people 90 days to 90+ years old. Supported by a team of more than 37,000 dedicated professionals, Life Time is committed to providing the best programs and experiences through its clubs, iconic athletic events and comprehensive digital platform.

Contacts:

Investors ? Ken Cooper, Investor Relations // [email protected] or 952-406-2322

 

SOURCE Life Time Group Holdings, Inc.


These press releases may also interest you

at 17:15
Delcath Systems, Inc. (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company's...

at 17:14
VESICA HEALTH, INC., a leading multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, today announced the launch of its laboratory-developed AssureMDxtm test....

at 17:00
Dr. Michael Gartner is fully certified as a plastic surgeon by the American Board of Plastic Surgery and is also fully certified as a general surgeon by the American Board of Surgery. As a Fellow of the American College of Surgeons, he is one of the...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...

at 16:48
The law firms of Kessler Topaz Meltzer & Check, LLP and Carella, Byrne, Cecchi, Brody & Agnello, P.C. inform current and former SilverScript Part D beneficiaries that the firms have filed a class action lawsuit against CVS Health Corporation,...



News published on and distributed by: